Nicotinamide Phosphoribosyltransferase Pipeline Overview and Precise Analysis of Therapeutic Activities in 2017
A latest pipeline report, titled "Nicotinamide Phosphoribosyltransferase (Visfatin or Pre B Cell Colony Enhancing Factor 1 or NAMPT or EC 2.4.2.12) - Pipeline Review, H2 2017" has been included in the extensive research repository of Market Research Hub (MRH) recently. This report outlays comprehensive information on the Nicotinamide Phosphoribosyltransferase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by companies/universities. According to this report,...
View full press release